Baldur Magnusson - Concepedia

Author

Baldur Magnusson

Novartis (Switzerland)ORCID

Also Known As

Baldur Magnusson, Baldur P. Magnusson, Magnusson, Baldur, Magnusson, Baldur P.

Publications

992

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Novartis (United States)Novartis (China)Novartis (India)Novartis (Singapore)

About

Baldur Magnusson is an author at Novartis (Switzerland) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	332
2	Public Health	2	2	43
3	Allergy	1	1	108
4	Allergy Medicine	1	1	108
5	Biostatistics	1	1	28

Baldur Magnusson

Publications

965

Citations

H-Index

Page 1

	Year	Citations
Spiroindolone KAE609 for Falciparum and Vivax Malaria Nicholas J. White, Sasithon Pukrittayakamee, Aung Pyae Phyo, New England Journal of Medicine	2014	244
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma Veit J. Erpenbeck, Todor A. Popov, David Miller, Pulmonary Pharmacology & Therapeutics AsthmaAllergyUncontrolled Allergic AsthmaAllergy MedicineMedicine	2016	108
Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria Nicholas J. White, Tran Thanh Duong, Chirapong Uthaisin, New England Journal of Medicine	2016	107
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers F. Joel Leong, Ruobing Li, Jay Prakash Jain, Antimicrobial Agents and Chemotherapy Drug SafetyHealthy Adult VolunteersPharmacological StudyAntiparasitic AgentMalaria	2014	103
Group sequential enrichment design incorporating subgroup selection Baldur Magnusson, Bruce W. Turnbull Statistics in Medicine	2013	85
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers F. Joel Leong, Rong Zhao, Shuqi Zeng, Antimicrobial Agents and Chemotherapy Antiparasitic AgentAbstract Kaf156MalariaPharmacotherapyPre-clinical Pharmacology	2014	66
Bayesian inference for a principal stratum estimand to assess the treatment effect in a subgroup characterized by postrandomization event occurrence Baldur Magnusson, Heinz Schmidli, Nicolas Rouyrre, Statistics in Medicine	2019	38
Estimation of the <i>In Vivo</i> MIC of Cipargamin in Uncomplicated Plasmodium falciparum Malaria Tran Tinh Hien, Nicholas J. White, Thuy-Nhien Nguyen, Antimicrobial Agents and Chemotherapy	2016	33
Phase II Study of Single/Repeated Doses of Acumapimod (BCT197) to Treat Acute Exacerbations of COPD Irina Strâmbu, Zhanna Kobalava, Baldur Magnusson, COPD Journal of Chronic Obstructive Pulmonary Disease	2019	32
Model averaging for treatment effect estimation in subgroups Björn Bornkamp, David Ohlssen, Baldur Magnusson, Pharmaceutical Statistics Bayesian StatisticPatient SelectionTreatment EffectQuasi-experimentModel Selection Uncertainty	2016	28

Page 1